A cellular therapeutic agent containing decidua-derived stem cells for urinary incontinence

This patent pertains to the cellular therapeutic agent containing decidua- or adipose-derived stem cells for treatment of urinary incontinence. To be more specific, it is regarding the cellular therapeutic agent containing decidua- or adipose-derived stem cells from the placenta or menstrual blood for treatment of urinary incontinence.

The decidua- or adipose-derived stem cells concerned have the effects of increasing the urinary leak point pressure and improving the contraction power of the urethral sphincter, making them useful as a treatment agent for urinary incontinence.

Leave a reply